Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Pediatric perampanel poisoning
1California Poison Control System, 200 W. Arbor Drive, San Diego, CA 92103, USA.
Insights
Perampanel overdose in children is not well-documented. Two pediatric cases show that even low doses can cause drowsiness, ataxia, and bradycardia, requiring intensive care.
Area of Science:
- Pediatric Neurology
- Clinical Toxicology
- Pharmacology
Background:
- Perampanel is an antiepileptic drug used to treat partial-onset seizures.
- Limited data exists regarding perampanel overdose, especially in pediatric populations.
Observation:
- Two cases of perampanel ingestion in 2-year-old children are presented.
- Case 1: Female ingested 0.77mg/kg, developing drowsiness and ataxia within 1 hour, followed by bradycardia at 6 hours. Required pediatric intensive care unit admission and fluid treatment.
- Case 2: Male ingested 0.25mg/kg, developing ataxia within 1 hour. Discharged after 6-hour emergency department observation without treatment.
Findings:
- Pediatric perampanel overdose can lead to significant neurological symptoms like ataxia and drowsiness.
- Bradycardia is a potential complication, even with moderate doses.
- Severity of symptoms may correlate with the ingested dose.
Implications:
- Highlights the need for increased awareness of perampanel toxicity in children.
- Suggests that even accidental pediatric ingestions warrant medical evaluation.
- Informs clinical management guidelines for perampanel overdose in young children.
Abstract:
There is no pediatric overdose information available for perampanel. We present twocases involving children 2 years of age. A female ingested 0.77mg/kg perampanel anddeveloped drowsiness and ataxia within an hour, followed by bradycardia after 6 hours.She was admitted to the pediatric intensive care unit and given fluids and was thendischarged after 20 hours. The other case involved a male who ingested 0.25mg/kgperampanel and developed ataxia within an hour, eventually he was discharged after 6hour observation in the emergency department without any treatment.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children

